Beneficial effect of interferon-β 1b treatment in patients with relapsing–remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy

Autor: Fainardi, Enrico *, Rizzo, Roberta, Melchiorri, Loredana, Castellazzi, Massimiliano, Govoni, Vittorio, Caniatti, Luisa, Paolino, Ezio, Tola, Maria Rosaria, Granieri, Enrico, Baricordi, Olavio Roberto
Zdroj: In Journal of Neuroimmunology 2004 148(1):206-211
Databáze: ScienceDirect